Find comprehensive information on Spontaneous Bacterial Peritonitis (SBP) diagnosis, including clinical documentation requirements, medical coding guidelines, and healthcare best practices. Learn about ascites culture, paracentesis, neutrophil count, and SAAG calculation for accurate SBP diagnosis and appropriate ICD-10 coding. This resource provides valuable insights for physicians, nurses, and medical coders seeking to improve the accuracy and efficiency of SBP diagnosis and documentation.
Bacterial infection of ascitic fluid without an apparent source.
Fever, abdominal pain, ascites, altered mental status, low blood pressure.
Cirrhosis, liver failure, ascites, immunocompromised patients.
Complete code families applicable to K65.2
| Description | When to use |
|---|---|
| Spontaneous Bacterial Peritonitis | Ascites infection without clear source in cirrhosis. Suspect fever, abdominal pain, altered mental status. |
| Secondary Bacterial Peritonitis | Peritonitis from bowel perforation, abscess, or other intra-abdominal infection. Look for localized signs. |
| Culture-Negative Neutrocytic Ascites | Neutrophils >250/mm3 in ascites, negative cultures. Consider SBP treatment if high clinical suspicion. |
Coding SBP without specifying organism or underlying cause (e.g., cirrhosis) leads to inaccurate severity and reimbursement.
Insufficient documentation of paracentesis procedure, including positive ascites culture, impacts code assignment and audit validity.
Miscoding secondary peritonitis (e.g., perforation) as SBP due to similar symptoms can lead to incorrect diagnosis reporting.
Ascites fluid PMN count >= 250/mm3?
Check SAAG (serum-ascites albumin gradient) > 1.1 g/dL?
Rule out secondary peritonitis (perforation, abscess)?
Culture ascites fluid before antibiotics
Document clinical findings, PMN count, and SAAG
Spontaneous bacterial peritonitis (SBP) diagnosed in a patient with ascites. Patient presents with classic SBP symptoms including fever, abdominal pain, and altered mental status. Physical examination reveals abdominal tenderness and distension. Paracentesis performed, revealing cloudy ascitic fluid. Ascitic fluid analysis demonstrates a polymorphonuclear (PMN) cell count greater than 250 cellsmm3, consistent with the diagnostic criteria for SBP. No evidence of a secondary cause of peritonitis identified. Patient has a history of cirrhosis and hepatic encephalopathy, increasing their risk for SBP. Blood cultures drawn. Intravenous antibiotic therapy initiated with a third-generation cephalosporin, such as cefotaxime, for empiric SBP treatment. Patient's Model for End-Stage Liver Disease (MELD) score calculated for prognostication and assessment of liver disease severity. Diagnosis codes for SBP, cirrhosis, and hepatic encephalopathy will be documented for accurate medical coding and billing. Patient will be monitored closely for response to therapy and development of complications such as hepatorenal syndrome. Prophylactic antibiotic therapy will be considered for secondary prophylaxis of SBP recurrence.
Differentiating Spontaneous Bacterial Peritonitis (SBP) from secondary bacterial peritonitis hinges on identifying the source of infection. SBP, by definition, arises without an intra-abdominal, surgically treatable source. Secondary bacterial peritonitis, on the other hand, results from a source such as a perforated bowel, appendicitis, or a leaking abscess. Clinically, both can present with similar symptoms like fever, abdominal pain, and altered mental status. Key diagnostic clues for secondary peritonitis include localized abdominal tenderness, guarding, or imaging findings suggestive of a focal source. A thorough history, physical exam, and imaging studies (e.g., CT abdomen) are crucial for accurate diagnosis. Lab analysis of ascitic fluid in SBP typically reveals a PMN count greater than 250 cells/mm3, often with a monobacterial culture. Explore how ascitic fluid analysis can help pinpoint the cause of peritonitis. Consider implementing a standardized diagnostic approach for evaluating ascites to ensure accurate and timely differentiation.
The recommended empiric antibiotic treatment for Spontaneous Bacterial Peritonitis (SBP) often involves a third-generation cephalosporin, such as cefotaxime or ceftriaxone. Fluoroquinolones like ofloxacin or ciprofloxacin may be considered in areas with low rates of quinolone resistance. Given the increasing prevalence of multidrug-resistant organisms, particularly in patients with prior antibiotic exposure or healthcare-associated SBP, antibiotic selection should be guided by local resistance patterns and institutional guidelines. Treatment duration typically ranges from 5 to 7 days and should be adjusted based on clinical response and culture results. Learn more about the emerging challenges of antibiotic resistance in SBP and explore strategies for optimizing antibiotic stewardship in patients with cirrhosis.
Preventing Spontaneous Bacterial Peritonitis (SBP) recurrence is paramount in managing patients with cirrhosis, especially those with a history of variceal bleeding, which signifies a higher risk. Prophylactic antibiotic therapy, using agents like norfloxacin or ciprofloxacin, is recommended for patients with a prior episode of SBP or those with low ascitic fluid protein levels (less than 1.5 g/dL) combined with other risk factors like impaired renal function or variceal bleeding. Consider implementing a long-term prophylactic antibiotic strategy for high-risk patients. Alongside antibiotics, strategies to optimize liver function and manage complications of portal hypertension are essential. Learn more about the latest guidelines for SBP prophylaxis and explore the role of albumin in preventing recurrence.
Clinical accuracy: This information is provided for documentation and coding guidance and should not replace professional medical judgment.
Coding standard: ICD-10-CM, current FY guidelines.